 |
Journal articles
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa
Abstract : To eliminate hepatitis B virus (HBV) infection, it is essential to scale up antiviral treatment through decentralized services. However, access to the conventional tools to assess treatment eligibility (liver biopsy/Fibroscan®/HBV DNA) is limited and not affordable in resource-limited countries. We developed and validated a simple score to easily identify patients in need of HBV treatment in Africa.
Cited literature [40 references]
https://hal-pasteur.archives-ouvertes.fr/pasteur-01896895
Contributor : Anne Lassailly-Bondaz Connect in order to contact the contributor
Submitted on : Tuesday, October 16, 2018 - 3:47:06 PM
Last modification on : Thursday, April 7, 2022 - 10:10:24 AM
Long-term archiving on: : Thursday, January 17, 2019 - 2:56:25 PM
Contributor : Anne Lassailly-Bondaz Connect in order to contact the contributor
Submitted on : Tuesday, October 16, 2018 - 3:47:06 PM
Last modification on : Thursday, April 7, 2022 - 10:10:24 AM
Long-term archiving on: : Thursday, January 17, 2019 - 2:56:25 PM
File
1-s2.0-S0168827818321020-main....
Publication funded by an institution
Licence
Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License